"dr-reddys"

Dr Reddy's Laboratories reported a 14.5 per cent rise in consolidated Q2 profit to Rs 1,437 crore, driven by strong branded sales. Revenue grew to Rs 8,805 crore, with robust performance in Europe, India, and emerging markets offsetting North America declines

Penalty imposed on the company for deviation from prescribed guidelines in filing intimation of import of a reference standard for one of the APIs

Dr Reddy’s had launched the anti-cancer drug Versavo in India in 2019 and later it was launched in other countries, the product was launched under the brand name Persivia

Topping the Hyderabad billionaires in the Forbes roster is Murali Divi and family, securing the 33rd spot with a staggering net worth of $6.3 billion.

Hyderabad: Dr Reddy’s Laboratories entered into an exclusive sales and distribution agreement with Novartis India for the Voveran range, the Calcium range, and Methergine in India. Under the arrangement, Dr Reddy’s will have exclusive rights to promote and distribute these products in India. The company will use its strengths in promotion and distribution to considerably […]

Sputnik Light is a one-dose vaccine and the same as the first component— recombinant human adenovirus serotype number 26 (rAd26) — of the two-dose Sputnik V vaccine, Dr Reddy's said in a statement.

Hyderabad: Hyderabad-based Dr Reddy’s Laboratories entered into a definitive agreement to acquire Nimbus Health GmbH, a privately owned, licensed pharmaceutical wholesaler from Germany focusing on medical cannabis. Dr Reddy’s will acquire Nimbus Health for an upfront payment plus performance and milestone-based earn-outs over the next four years. Founded in 2018, Nimbus Health is one of […]

Hyderabad: Dr Reddy’s Laboratories launched the prescription drug Minoxidil topical solution USP 2 per cent and 5 per cent for the treatment of female pattern hair loss (FPHL). The company will sell its products under the brand name Mintop. The launch follows the first-ever approval of the additional indication by the Central Drugs Standard Control […]

Under the terms of agreement, Dr Reddy’s will receive $40 million upfront upon the closing of the transaction, followed by approval milestone payment of up to $40 million related to the CTCL (cutaneous T-cell lymphoma)

Hyderabad: Hyderabad-based Dr Reddy’s Laboratories launched generic Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules in the US market, used for treatment of stomach ulcers, irritable bowel syndrome and inflammation of the colon. The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market. The product is a generic version […]

In addition, Vinod Nair, Head of Research at Geojit Financial Services said the upcoming week will be driven by global sentiments.

Soft launch of Sputnik V vaccine reaches over 50 cities and towns, after initial launch in Hyderabad on May 14

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s

On successful completion of the clinical trial, each company will independently approach the regulatory authorities for approval to manufacture and supply the drug for the treatment of Covid-19 in India

Being a limited pilot phase presently, registration on CoWIN is not open yet to public, but will become open at the time of commercial launch.

The Hyderabad-based drug major is voluntarily recalling the affected lots of the drug in 10 mg strength due to “failed impurities degradation specifications”.

"With this partnership with Dr Reddy’s, we aim to reach maximum institutions administering vaccines through our five high-capacity temperature-controlled warehouses," said Sunil Nair, CEO, Snowman Logistics.

Hyderabad firm says it will not take responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from fraud in the name of Sputnik V vaccine

The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications.

The drug firm over the past few weeks has ramped up supply of multiple medicines including Remdesivir to meet the surge in demand.